Jason Fredette | executive |
Martin Huber | executive |
Brian DeSchuytner | executive |
Tara Bancroft | analyst |
Jonathan Chang | analyst |
Ashiq Mubarack | analyst |
Colleen Hanley | analyst |
Michael Schmidt | analyst |
Asthika Goonewardene | analyst |
Lut Ming Cheng | analyst |
Good morning, and welcome to the Mersana Therapeutics Fourth Quarter 2023 Conference Call and Webcast. [Operator Instructions] Please note, this call is being recorded. I would now like to turn the call over to Jason Fredette, Senior Vice President, Investor Relations and Corporate Communications.
Thank you, operator, and good morning, everyone.
Before we begin, please note that this call will contain forward-looking statements within the meaning of federal securities laws.